SCHEMBL9998418

SCHEMBL9998418

CC(=O)OC(OC(C)=O)C(=Cc1cccc(F)c1)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.41
AKR1C2 P52895 1/20 0.41
PPARG P37231 2/20 0.40
PPARA Q07869 1/20 0.40
PTGS1 P23219 2/20 0.40
AKR1C3 P42330 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
NFE2L2 Q16236 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
SRC P12931 1/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
RAB9A P51151 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998417 1.00 CNR2 (0.42) CNR2MAPTTSHRAKR1C2PPARG
SCHEMBL9998023 0.87 CYP3A4 (0.50) CNR2TSHRAKR1C3KMT2AMEN1
SCHEMBL9998025 0.87 CYP3A4 (0.50) CNR2TSHRAKR1C3KMT2AMEN1
SCHEMBL9997710 0.86 TSHR (0.42) CNR2TSHRKMT2AMEN1CYP3A4
SCHEMBL9997711 0.86 TSHR (0.42) CNR2TSHRKMT2AMEN1CYP3A4
SCHEMBL9997837 0.86 TSHR (0.42) MAPTTSHRPPARGPPARAKMT2A
SCHEMBL9997839 0.86 TSHR (0.42) MAPTTSHRPPARGPPARAKMT2A
SCHEMBL9998089 0.86 ALDH1A1 (0.46) CNR2MAPTTSHRPPARGPPARA
SCHEMBL9998091 0.86 ALDH1A1 (0.46) CNR2MAPTTSHRPPARGPPARA
SCHEMBL9998113 0.85 TSHR (0.41) CNR2TSHRPPARGKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CNR2 1173/4885MAPT 2206/4885TSHR 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.